Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by thadeushon Nov 18, 2017 1:14pm
145 Views
Post# 26989621

Treat/replace upper tract?

Treat/replace upper tract?Given TLT's compounds and sensitivity to various light frequencies, and if the source of the recurrence can be established as the upper tract, what are the possibilities if TLT knows that going into the next trial/re-treatment? Can the upper tract be instilled with the sensitizer and exposed to light so it can be included in the treatment? Can the upper tract be replaced completely, some sort of "conduit diversion" so that it can no longer harbor cancer? I'm not a doctor (obviously), but it seems like if x-rays have the potential to eliminate GBM using the same sensitizer technology, they should be able to treat the upper tract somehow.      Also, if TLT is treating the bladder for bladder cancer, how far 'upstream' from the bladder is the treatment responsible for treating? If the cancer is also present in the upper tract or kidneys, is TLT's PDT treatment responsible for treating it? I doubt this was an issue for Keytruda.
Bullboard Posts